// App-Quantinova.ai

4544 : Cardiovascular toxicity following anti-angiogenic therapy in persons over age 65 with advanced renal cell carcinoma.

Researchers

Presenter

  • Sekwon Jang

Principal Investigators

  • Chaoyi Zheng

  • Michael B. Atkins

  • Andrew N Freeman

  • Lori M. Minasian

  • Arnold L. Potosky

  • Huei-Ting Tsai

  • Alex z Fu

  • Ana Barac

Medical Centers

  • Lombardi Comprehensive Cancer Center, Washington, DC

  • Inova Comprehensive Cancer and Research Institute, Fairfax, VANational Cancer Institute, Bethesda, MDLombardi Comprehensive Cancer Center, Georgetown University, Washington, DC

  • National Cancer Institute, Bethesda, MD

  • Medstar Washington Hosp Ctr, Washington, DC

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Central Nervous System (CNS)

Disease

  • Metastatic Renal Cell Cancer

  • Myocardial infarction

  • Congestive heart failure

  • Renal cell carcinoma

  • Heart muscle disease

  • Solid malignancies

  • Stroke

Biomarkers

  • X-Ray Repair Cross Complementing 1

Drug/Treatment

  • Sorafenib

  • Sunitinib

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved